[ad_1]
Shares of Dow Inc. dove toward an eight-month low Thursday, after the materials-science company missed on second-quarter earnings, citing continued weakness in the economy.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...